Vice PresidentQiu Qiyu

Institute. He is the first group ambassador of Wuhan Overseas Chinese Association, part-time vice chairman of Wuhan Overseas Chinese Association, vice president of Wuhan Western Returned Scholars Association Biotown Branch, vice president of Hubei Changjiang International Chamber of Commerce.

Senior Scientist, Oncology Research Center, Royal Victoria Hospital, McGill University, Canada, and American Pharmaceutical Resources, Inc., Member of the Graduate School of McGill University, President of the US-China Innovation Alliance in Washington, DC, and Vice President of the US-China Joint Chamber of Commerce.

He is committed to the research and development of a series of original novel class I targeted anticancer drugs and their industrialization. He has published more than 50 professional articles in international famous academic journals, and has developed 48 new drugs, among which 6 drugs have been uniformly named by the National Institutes of Health of the United States. To promote cooperation, exchanges and innovation in the field of medicine between China and the United States.